Tesamorelin is a synthetic analogue of growth hormone-releasing hormone, or GHRH, studied for its effects on growth-hormone signaling, IGF-1 pathways, visceral-fat metabolism, body-composition markers, glucose-related biomarkers, and broader endocrine-function research.
Potential Human Benefits Being Investigated
- Growth-hormone signaling research
- IGF-1 pathway research
- Visceral-adipose-tissue reduction research
- HIV-associated lipodystrophy research
- Body-composition biomarker research
